Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. The company offers drugs for anti-HBV, liver diseases, hepatobiliary disease drugs, metabolism and digestive system, respiratory, cardiovascular, men's health, and other fields. It also provides technical services such as drug development, including the development and quality research of active pharmaceutical ingredients (APIs) and formulation processes. Fujian Cosunter Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Fuzhou, China.
Frequently asked questions
What sector does Fujian Cosunter Pharmaceutical Co Ltd (300436) operate in?
Fujian Cosunter Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Fujian Cosunter Pharmaceutical Co Ltd (300436) current stock price?
As of the latest data, Fujian Cosunter Pharmaceutical Co Ltd stock price is CN¥100.65, with a previous close of CN¥98.21. Fujian Cosunter Pharmaceutical Co Ltd gained CN¥2.44 in the last trading session, representing a 2.48% increase.
What is Fujian Cosunter Pharmaceutical Co Ltd (300436) current market capitalization?
Fujian Cosunter Pharmaceutical Co Ltd market cap is approximately 16.03 billion.
What is Fujian Cosunter Pharmaceutical Co Ltd (300436) Earnings Per Share (EPS)?
The trailing EPS is -CN¥1.35.
Does Fujian Cosunter Pharmaceutical Co Ltd (300436) pay dividends?
No. Fujian Cosunter Pharmaceutical Co Ltd does not pay a dividend.
What is Fujian Cosunter Pharmaceutical Co Ltd (300436) beta (volatility) score?
Fujian Cosunter Pharmaceutical Co Ltd has a beta of 1.149, meaning its volatility is roughly in line with the market.
